In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) closed the day trading at $0.62 down -11.00% from the previous closing price of $0.70. In other words, the price has decreased by -$11.00 from its previous closing price. On the day, 92892.0 shares were traded. NMTC stock price reached its highest trading level at $0.6794 during the session, while it also had its lowest trading level at $0.5771.
Ratios:
For a better understanding of NMTC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.36 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on March 29, 2022, Downgraded its rating to Hold and sets its target price to $2 from $6 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 06 ’24 when Christianson Mark sold 2,189 shares for $0.88 per share. The transaction valued at 1,918 led to the insider holds 295,035 shares of the business.
Christianson Mark sold 25,800 shares of NMTC for $22,663 on Jun 05 ’24. The Business Development Director now owns 297,224 shares after completing the transaction at $0.88 per share. On Dec 27 ’23, another insider, Christianson Mark, who serves as the Business Development Director of the company, sold 31,445 shares for $1.46 each. As a result, the insider received 45,859 and left with 300,594 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMTC now has a Market Capitalization of 19112622 and an Enterprise Value of 17782722. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.88 while its Price-to-Book (P/B) ratio in mrq is 5.74. Its current Enterprise Value per Revenue stands at 4.534 whereas that against EBITDA is -1.483.
Stock Price History:
Over the past 52 weeks, NMTC has reached a high of $2.00, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -30.69%, while the 200-Day Moving Average is calculated to be -35.38%.
Shares Statistics:
Over the past 3-months, NMTC traded about 92.34K shares per day on average, while over the past 10 days, NMTC traded about 229620 shares per day. A total of 30.81M shares are outstanding, with a floating share count of 27.15M. Insiders hold about 11.87% of the company’s shares, while institutions hold 19.43% stake in the company. Shares short for NMTC as of 1731628800 were 107074 with a Short Ratio of 1.16, compared to 1728950400 on 128380. Therefore, it implies a Short% of Shares Outstanding of 107074 and a Short% of Float of 0.36000002.
